The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
The CLS Blue Sky blog includes an interesting new post on decisions from SCOTUS and others that accept the legal sufficiency of allegations of "willful blindness" in the corporate boardroom. The article also touches on potential implications for Caremark claims regarding board failure to foresee and/or manage risks.
Just before the weekend, DuPont, Corteva and Chemours issued a joint press release announcing a $4 billion deal to resolve their respective obligation related to underlying PFAS claims. The deal arise
These are interesting times with respect to corporate transactions related to alleged or actual fraudulent conveyances, whether arising through private equity deals or efforts to limit the costs of le
Over the last couple of years, defense oriented commentators have used the meme “event driven securities litigation” as part of complaining about the increasing volume of class action litigation. From